These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11266749)

  • 1. Portal venous tolerance in the anti-class I L(d) alloantigen 2C transgenic mouse.
    Margenthaler JA; Yu S; Otomo N; Shimizu Y; Flye MW
    Transplant Proc; 2001; 33(1-2):143-4. PubMed ID: 11266749
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed type hypersensitivity in the CD8+ dominant anti-class I L(d) alloantigen 2C transgenic mouse is mediated by small but significant CD4 population.
    Margenthaler JA; Otomo N; Shimizu Y; Yu S; Flye MW
    Transplant Proc; 2001; 33(1-2):338-9. PubMed ID: 11266850
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the induction of tolerance to alloantigens. II. The generation of serum factor(s) able to transfer alloantigen-specific tolerance for delayed-type hypersensitivity by portal venous inoculation with allogeneic cells.
    Fujiwara H; Qian JH; Satoh S; Kokudo S; Ikegami R; Hamaoka T
    J Immunol; 1986 Apr; 136(8):2763-8. PubMed ID: 2420865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenetic analysis of tolerance induction in anti-alloantigen delayed type hypersensitivity responses by portal venous pre-inoculation with allogeneic cells.
    Shimizu J; Ogata M; Qian JH; Sato S; Kokudo S; Hamaoka T; Fujiwara H
    Microbiol Immunol; 1987; 31(4):367-74. PubMed ID: 3475532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
    Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
    J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    J Surg Res; 2002 May; 104(1):29-35. PubMed ID: 11971674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathymic alloantigen-mediated tolerant, completely MHC-mismatched mouse hearts are specifically rejected by adoptively transferred in vitro-sensitized anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler JA; Tu F; Flye MW
    Transplant Proc; 2001; 33(1-2):159-60. PubMed ID: 11266758
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
    Margenthaler JA; Kataoka M; Flye WM
    J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed chimerism and transplant tolerance are not effectively induced in C3a-deficient mice.
    Baśkiewicz-Hałasa M; Rogińska D; Piecyk K; Hałasa M; Lejkowska R; Pius-Sadowska E; Machaliński B
    Exp Hematol; 2015 Jan; 43(1):14-22. PubMed ID: 25308956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Property of class I H-2 alloantigen-reactive Lyt-2+ helper T cell subset. Abrogation of its proliferative and IL-2-producing capacities by intravenous injection of class I H-2-disparate allogeneic cells.
    Sato S; Azuma T; Shimizu J; Shima J; Kitagawa S; Hamaoka T; Fujiwara H
    J Immunol; 1988 Aug; 141(3):721-7. PubMed ID: 2456330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
    Margenthaler JA; Kataoka M; Flye MW
    Transpl Immunol; 2004 Jan; 12(2):133-41. PubMed ID: 14967311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV core protein-expressing DNA vaccine induces a strong class I-binding peptide DTH response in mice.
    Acosta-Rivero N; Dueñas-Carrera S; Alvarez-Lajonchere L; Morales-Grillo J
    Biochem Biophys Res Commun; 2004 Feb; 314(3):781-6. PubMed ID: 14741703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.